399 Lynce F, Barac A, Geng X, Dang C, Yu AF, Smith KL, et al. Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2- positive breast cancer and compromised heart function: the SAFE-HEaRt study. Here, ERBB2 is linked to breast carcinoma.